title: Inhibitors of HIV-1 transcription.
abstract: No curative drug against HIV has yet been found, despite enormous efforts aimed at reverse transcriptase and a variety of other targets. The long terminal repeat (LTR) of HIV-1 has recently become a promising site for antiviral action. This article briefly summarizes information on the nature of this target and potential anti-LTR expression drugs.
authors.affiliation: Divn of Cell Growth and Regulation, Dana-Farber Cancer Institute, Boston, MA 02115.
authors.forename: C J
authors.initials: CJ
authors.lastname: Li
authors.forename: B J
authors.initials: BJ
authors.lastname: Dezube
authors.forename: D K
authors.initials: DK
authors.lastname: Biswas
authors.forename: C M
authors.initials: CM
authors.lastname: Ahlers
authors.forename: A B
authors.initials: AB
authors.lastname: Pardee
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000998:Antiviral Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001483:Base Sequence; D016325:HIV Long Terminal Repeat / Q000235:genetics*; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D008954:Models, Biological; D008969:Molecular Sequence Data; D014158:Transcription, Genetic / Q000187:drug effects*; D015533:Transcriptional Activation / Q000187:drug effects
chemical_list: D000998:Antiviral Agents